4.7 Article

Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant Enterobacterales in Decompensated Cirrhosis

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure

Florence Wong et al.

Summary: Bacterial infections can trigger acute-on-chronic liver failure, with varying rates and clinical characteristics in different geographic regions, particularly with the highest incidence in the Indian subcontinent.

JOURNAL OF HEPATOLOGY (2021)

Article Immunology

Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver Failure

Sabrina Rueschenbaum et al.

Summary: The study reveals that immune suppression occurs early in liver cirrhosis, and as ACLF develops, both innate and adaptive immune functions are progressively diminished, potentially increasing the risk of infections in patients with liver cirrhosis.

FRONTIERS IN IMMUNOLOGY (2021)

Review Pharmacology & Pharmacy

Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics

Peter Garred et al.

Summary: The complement system is the host's defense friend by protecting it from invading pathogens, promoting tissue repair, and maintaining homeostasis. Complement is a double-edged sword, since when dysregulated or overactivated it becomes the host's enemy, leading to tissue damage, organ failure, and, in worst case, death. A number of acute and chronic diseases are candidates for pharmacological treatment to avoid complement-dependent damage, ranging from the well established treatment for rare diseases to possible future treatment of large patient groups like the pandemic coronavirus disease 2019.

PHARMACOLOGICAL REVIEWS (2021)

Review Microbiology

Mechanism and Potential of Extracellular Vesicles Derived From Mesenchymal Stem Cells for the Treatment of Infectious Diseases

Jingyi You et al.

Summary: Extracellular vesicles (EVs) are nano-sized membrane vesicles secreted by cells, serving as a mediator for cell-to-cell communication. Mesenchymal stem cells-derived EVs (MSC-EVs) have shown therapeutic value in treating infectious diseases by eliminating pathogens, regulating immunity, and repairing tissue damage.

FRONTIERS IN MICROBIOLOGY (2021)

Review Cell Biology

Molecular Mechanisms of Multi-Organ Failure in COVID-19 and Potential of Stem Cell Therapy

Aditya Bhalerao et al.

Summary: As the number of confirmed cases and deaths from COVID-19 continues to rise globally, health experts are working hard to understand the damage caused by SARS-CoV-2. COVID-19 can lead to severe respiratory distress and systemic damage to major organs, with this review focusing on the molecular mechanisms of multi-organ failure in COVID-19 patients and the potential of stem cell therapy.

CELLS (2021)

Article Microbiology

Klebsiella pneumoniae Lipopolysaccharides Serotype O2afg Induce Poor Inflammatory Immune Responses Ex Vivo

Matteo Bulati et al.

Summary: Multidrug resistant Klebsiella pneumoniae with LPS O2afg serotypes are able to evade the initial inflammatory immune response and systematically spread inside the host, resulting in various pathologies associated with this bacterium.

MICROORGANISMS (2021)

Review Medicine, General & Internal

The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues

Ya Yang et al.

Summary: Mesenchymal stem cell (MSC) transplantation is a novel treatment for liver diseases, but the mechanisms are not fully understood. Despite significant efficacy in animal models and preliminary clinical trials, issues such as efficacy and safety remain. Therefore, more research is needed to address the challenging issues of MSC-based therapy in the treatment of liver diseases.

FRONTIERS IN MEDICINE (2021)

Review Medicine, General & Internal

The ambiguous role of mannose-binding lectin (MBL) in human immunity

Namarta Kalia et al.

Summary: MBL plays a crucial role in distinguishing self from non-self structures, with its function and concentration affected by various variants and secretor polymorphisms. High levels of MBL may increase susceptibility to diseases, but the level of deficiency is yet to be defined and requires interpretation based on specific population designs for diseases.

OPEN MEDICINE (2021)

Article Cell & Tissue Engineering

Human Amnion-Derived Mesenchymal Stromal Cells in Cirrhotic Patients with Refractory Ascites: A Possible Anti-Inflammatory Therapy for Preventing Spontaneous Bacterial Peritonitis

Mariangela Pampalone et al.

Summary: The study demonstrates that hA-MSCs can modulate the immune response in ascitic fluid from cirrhotic patients by reducing pro-inflammatory cytokine production and promoting anti-inflammatory M2 macrophage polarization without affecting M1-like cells. This highlights the potential of hA-MSCs in immunomodulation and provides insight into their role in conditions such as spontaneous bacterial peritonitis.

STEM CELL REVIEWS AND REPORTS (2021)

Review Cell Biology

Medicinal signaling cells: A potential antimicrobial drug store

Seyed Mahdi Hosseiniyan Khatibi et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Article Gastroenterology & Hepatology

Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic rats

Giada Pietrosi et al.

LIVER INTERNATIONAL (2020)

Review Immunology

Defining trained immunity and its role in health and disease

Mihai G. Netea et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Medicine, General & Internal

Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis

Oluyemi Komolafe et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)

Review Genetics & Heredity

Exploring the roles of MSCs in infections: focus on bacterial diseases

Pasquale Marrazzo et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2019)

Article Gastroenterology & Hepatology

Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

Salvatore Piano et al.

GASTROENTEROLOGY (2019)

Review Microbiology

Klebsiella pneumoniae infection biology: living to counteract host defences

Jose A. Bengoechea et al.

FEMS MICROBIOLOGY REVIEWS (2019)

Review Immunology

Causes and Consequences of Innate Immune Dysfunction in Cirrhosis

Katharine Margaret Irvine et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Gastroenterology & Hepatology

Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies

Sebastian Marciano et al.

HEPATIC MEDICINE-EVIDENCE AND RESEARCH (2019)

Review Immunology

New insights into the immune functions of complement

Edimara S. Reis et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Review Immunology

The complement system in liver diseases: Evidence-based approach and therapeutic options

Thomas Lung et al.

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2019)

Article Gastroenterology & Hepatology

Prognostic value of lectin pathway molecules and complement proteins in ascitic fluid and blood in patients with liver cirrhosis

Signe Glargaard et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)

Review Immunology

Implications of macrophage polarization in autoimmunity

Samanta C. Funes et al.

IMMUNOLOGY (2018)

Article Biochemistry & Molecular Biology

Species-specific differences in regulation of macrophage inflammation by the C3a-C3a receptor axis

Tathagat Dutta Ray et al.

INNATE IMMUNITY (2018)

Review Immunology

Diseases of complement dysregulation-an overview

Edwin K. S. Wong et al.

SEMINARS IN IMMUNOPATHOLOGY (2018)

Article Cell & Tissue Engineering

Human amnion favours tissue repair by inducing the M1-to-M2 switch and enhancing M2 macrophage features

Marta Magatti et al.

JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2017)

Article Multidisciplinary Sciences

Ficolins do not alter host immune responses to lipopolysaccharide-induced inflammation in vivo

Ninette Genster et al.

SCIENTIFIC REPORTS (2017)

Review Immunology

Production of complement components by cells of the immune system

R. Lubbers et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)

Review Immunology

A journey through the lectin pathway of complementMBL and beyond

Peter Garred et al.

IMMUNOLOGICAL REVIEWS (2016)

Review Immunology

Protection of host cells by complement regulators

Christoph Q. Schmidt et al.

IMMUNOLOGICAL REVIEWS (2016)

Review Immunology

Complement component C3-The Swiss Army Knife of innate immunity and host defense

Daniel Ricklin et al.

IMMUNOLOGICAL REVIEWS (2016)

Article Immunology

Low ficolin-2 levels in common variable immunodeficiency patients with bronchiectasis

M. -L. Metzger et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)

Review Biochemistry & Molecular Biology

MBL-associated serine proteases (MASPs) and infectious diseases

Marcia H. Beltrame et al.

MOLECULAR IMMUNOLOGY (2015)

Review Cell & Tissue Engineering

Complement activation in the context of stem cells and tissue repair

Ingrid Schraufstatter et al.

WORLD JOURNAL OF STEM CELLS (2015)

Review Gastroenterology & Hepatology

Bacterial translocation (BT) in cirrhosis

R Wiest et al.

HEPATOLOGY (2005)